These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of n-3 fatty acids on low density lipoprotein subfractions. Griffin BA Lipids; 2001; 36 Suppl():S91-7. PubMed ID: 11837999 [TBL] [Abstract][Full Text] [Related]
4. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051 [TBL] [Abstract][Full Text] [Related]
5. Small, dense low-density lipoprotein as a risk factor for coronary heart disease. Austin MA Int J Clin Lab Res; 1994; 24(4):187-92. PubMed ID: 7894041 [TBL] [Abstract][Full Text] [Related]
6. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. Tani S; Matsumoto M; Nagao K; Hirayama A J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623 [TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088 [TBL] [Abstract][Full Text] [Related]
8. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. Rhoads GG; Gulbrandsen CL; Kagan A N Engl J Med; 1976 Feb; 294(6):293-8. PubMed ID: 173994 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. Hiki M; Shimada K; Ohmura H; Kiyanagi T; Kume A; Sumiyoshi K; Fukao K; Inoue N; Mokuno H; Miyazaki T; Daida H J Cardiol; 2009 Feb; 53(1):108-16. PubMed ID: 19167646 [TBL] [Abstract][Full Text] [Related]
15. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations. Rössner S J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957 [No Abstract] [Full Text] [Related]
16. Lipoproteins, cardiovascular disease, and death. The Framingham study. Gordon T; Kannel WB; Castelli WP; Dawber TR Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370 [TBL] [Abstract][Full Text] [Related]
17. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease. Biswas S; Ghoshal PK; Mandal SC; Mandal N J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385 [TBL] [Abstract][Full Text] [Related]
18. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)]. Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG Lab Delo; 1983; (6):29-38. PubMed ID: 6193318 [No Abstract] [Full Text] [Related]
19. Lipid measurements for coronary risk assessment: a review. Berg LH Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628 [TBL] [Abstract][Full Text] [Related]